Brian Wright

Sterne Agee released a company report on Thursday highlighting Aetna Inc (NYSE: AET). Sterne Agee upgraded Aetna from Neutral to Buy with a $124 price target. Analyst Brian Wright wrote, "We see Aetna as the best positioned within the large-cap health plan space for investors to be positioned to...

UnitedHealth Group Inc. (NYSE: UNH) investors might be hard-pressed to find further gains in the stock, an analyst said Wednesday. Shares of the company are up nearly 50 percent in the past year, and were trading higher Wednesday on better-than-expected fourth quarter results. But Sterne Agee...

Hospital investors faced with uncertainty over pending Supreme Court arguments regarding Obamacare should rest comfortably, an analyst said Friday. Coming before the court in March is whether subsidies for the five million people receiving health insurance through federal exchanges are legal...

Higher levels of influenza in the current season should help to enrich hospital investors while tending to impoverish shareholders of health insurance concerns, an analyst said Friday. Commenting on data from the Centers for Disease Control, Sterne Agee's Brian Wright noted that flu cases...

Sterne Agee analyst Brian Wright issued comments Monday on the upcoming Supreme Court review involving the Affordable Care Act, often referred to as Obamacare. "On Friday afternoon, the U.S. Supreme Court (SCOTUS) announced that it will hear the King vs. Burwell case that questions the...

Sterne Agee issued a Medicaid Plan Q3 preview report on Wednesday. Sterne Agee maintained the following ratings, price targets and Q3 EPS estimates: Centene Corp (NYSE: CNC) - Buy, $96 price target, $0.94 EPS Molina Healthcare, Inc. (NYSE: MOH) - Buy, $69 price target, $0.42 EPS...

Sterne Agee lowered its rating on Cigna Corporation (NYSE: CI) from Buy to Neutral in a report issued Tuesday with a $110 price target. Analyst Brian Wright continued to "view CI's international assets as under appreciated," however, he was "increasingly concerned about the...

Sterne Agee analyst Brian Wright upgraded Wellcare Health Plans (NYSE: WCG) from Underperform to Neutral. Wright also lowered his price target and earnings due to outlook that indicates increases in medical care ratio for Medicare Advantage and prescription drug plans. Wright lowered his EPS...

In a report published Monday, Sterne Agee analyst Brian Wright reiterated an Underperform rating on UnitedHealth Group (NYSE: UNH), and raised the price target from $80.00 to $87.00. In the report, Sterne Agee noted, “While our long-term view is supportive, we continue to expect less near-term...

In a report published Friday, Sterne Agee analyst Brian Wright initiated coverage on Molina Healthcare (NYSE: MOH) with a Buy rating and $69.00 price target. In the report, Sterne Agee noted, “We believe MOH shares do not fully reflect normalized earnings power and investors receive post '15 top-...

In a report published Friday, Sterne Agee analyst Brian Wright initiated coverage on WellCare Health Plans (NYSE: WCG) with an Underperform rating and $76.00 price target. In the report, Sterne Agee noted, “We believe there is a certain element of acquisition expectations embedded in WellCare...

In a report published Friday, Sterne Agee analyst Brian Wright initiated coverage on Aetna (NYSE: AET) with a Neutral rating and $87.00 price target. In the report, Sterne Agee noted, “Aetna is executing supremely well in a challenging environment. However, we see less earnings power upside...

In a report published Friday, Sterne Agee analyst Brian Wright initiated coverage on UnitedHealth Group (NYSE: UNH) with an Underperform rating and $80.00 price target. In the report, Sterne Agee noted, “While the premier company in the industry, even the best have rough patches and we believe this...

In a report published Friday, Sterne Agee analyst Brian Wright initiated coverage on WellPoint (NYSE: WLP) with a Neutral rating and $130.00 price target. In the report, Sterne Agee noted, “WelllPoint shares trade at a discount to long-term sustainable earnings power and reserve growth in 1Q14 was...